Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...

With millions of Americans taking GLP-1 medications for weight loss, the thought of taking one of these medications might ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

A surge in the use of GLP-1 drugs is among the reasons a new report projects a calorie intake decline of 10 quadrillion in U.S. adults by 2030.

We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...